Quantcast Nonbarbiturate sedative and hypnotics - Pharmacology I

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
c.
Intermediate-Acting Barbiturates.
(1)  Basic information. Intermediate-acting barbiturates have a duration of
action that lasts from 4 hours to 6 hours. These agents are mainly use for the initial and
short-term treatment of insomnia.
Example of intermediate-acting barbiturate. Amobarbital (Amytal).
(2)
d.
Long-Acting Barbiturates.
(1)  Basic information. Long-acting barbiturates have a duration of action
that lasts from 6 hours to 8 hours. These agents are used orally to maintain daylong
sedation in anxiety-tension states. Furthermore, long-acting barbiturates are useful in
the treatment of various convulsive disorders.
(2)
Examples of long-acting barbiturates.
(a)
Phenobarbital.
Mephobarbital (Mebaral).
(b)
7-9. NONBARBITURATE SEDATIVES AND HYPNOTICS
a.
Short-Acting Agents.
(1)  Background information. Short-acting nonbarbiturate sedative-hypnotics
are generally used orally in the initial and short-term treatment of insomnia.
(2)
Examples of short-acting nonbarbiturate sedative-hypnotics.
(a)  Chloral hydrate (Noctec). Drug interactions may occur between
chloral hydrate and anticoagulants, furosemide, alcohol, or other drugs that are CNS
depressants.
(b)  Triazolam (Halcion). Triazolam is rapidly absorbed through the
oral route and is as effective as the barbiturates in inducing sleep. It is excreted in
breast milk and should not be administered to nursing mothers.
b.
Intermediate-Acting Agents.
(1)  Background information. Intermediate-acting nonbarbiturate agents are
administered orally to effectively control moderate to severe daytime anxiety and
tension in patients who have neuroses and mild depressive states.
(2)
Examples of intermediate-acting nonbarbiturates.
MD0804
7-8



Medical News
Proteins may slow memory loss in people with Alzheimer's
Certain proteins may slow the devastating memory loss caused by...
medicalxpress.com
Tpl2 enzyme may be target for treating autoimmune diseases
New research at the University of Georgia has found that...
medicalxpress.com
1950s drug is future heart treatment
Oxford University researchers have found a promising future treatment for...
medicalxpress.com
Faster heart rate linked to diabetes risk
An association between resting heart rate and diabetes suggests that...
medicalxpress.com
India's street dentists filling gap for the poor
Ignoring noisy buses and curious onlookers, street dentist Allah Baksh...
medicalxpress.com
Head injuries could result in neurodegenerative disease in rugby union players
A new article publishing online today in the Quarterly Journal...
medicalxpress.com
By the Book: How to Roll Out a New Chest Pain Pathway
(MedPage Today) -- A new chest pain protocol?...
medpagetoday.com
Time is muscle in acute heart failure
Urgent diagnosis and treatment in acute heart failure has been...
medicalxpress.com
Raising a glass to the holidays
Asking people about what they drink on holidays and other...
medicalxpress.com
10 Questions: Theodore A. Bass, MD
(MedPage Today) -- 'There has to be a way of...
medpagetoday.com
Women’s health experts tackle mood disorders and sexual assault
Earlier this week I reported from the Women’s Health Forum, held on...
scopeblog.stanford.edu
Mood instability common to mental health disorders and associated with poor outcomes
A study by researchers from the Institute of Psychiatry, Psychology...
medicalxpress.com
Research identifies best treatment for blood pressure in diabetic kidney disease
Blood pressure lowering drugs do not improve life expectancy among...
medicalxpress.com
Statins May Cut Stroke in Seniors (CME/CE)
(MedPage Today) -- Results won't change guidelines, but may be...
medpagetoday.com
Heroin Is Tops for Keeping Addicts in Treatment (CME/CE)
(MedPage Today) -- But finding says more about conflicting evidence...
medpagetoday.com
Applying visual techniques to med school lessons
Quick! When a person is deprived of oxygen, which part...
medicalxpress.com
PAD Patients Get Moving With Behavioral Therapy (CME/CE)
(MedPage Today) -- Intervention encourages at-home exercise, leading to mobility...
medpagetoday.com
A New Generation of Innovators
(MedPage Today) -- David Nash, MD, MBA, spotlights one medical...
medpagetoday.com
Smoking rates continue to drop in many states: CDC
(HealthDay)—Cigarette smoking continues to decline in about half of American...
medicalxpress.com
Breath-holding games are killing swimmers, CDC warns
(HealthDay)—As more adults and kids head to swimming pools, lakes...
medicalxpress.com
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +